An in vivo pharmacological study on muscarinic receptor subtypes regulating cholinergic neurotransmission in rat striatum.
D008455:(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride / Q000494:pharmacology; D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D002794:Choline / Q000502:physiology*; D003342:Corpus Striatum / Q000502:physiology*; D005260:Female; D010095:Oxotremorine / Q000031:analogs & derivatives / Q000494:pharmacology; D010890:Pirenzepine / Q000494:pharmacology; D051381:Rats; D011976:Receptors, Muscarinic / Q000502:physiology*; D012601:Scopolamine / Q000494:pharmacology; D009435:Synaptic Transmission / Q000187:drug effects
D011976:Receptors, Muscarinic; C049425:oxotremorine sesquifumarate; D010890:Pirenzepine; D008455:(4-(m-Chlorophenylcarbamoyloxy)-2-butynyl)trimethylammonium Chloride; D010095:Oxotremorine; D012601:Scopolamine; D002794:Choline; D000109:Acetylcholine